PD54-11 RESULTS OF THE PHASE 1 SAFETY AND EFFICACY PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) TARGETING FLUOROPHORE FOR IMAGE GUIDED SURGERY IN PATIENTS UNDERGOING ROBOTIC PROSTATECTOMY. (May 2022)